Studies have demonstrated that the positive regulation of CXCL8, together with CCL2, may contribute to the establishment of a malignant microenvironment that is favorable to leukemic cells in B-ALL [48]. The gene discussed is CCL2; the disease is precursor B-cell acute lymphoblastic leukemia.